From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have three major program areas: KFF Policy; KFF Polling; and KFF Health News (formerly Kaiser Health News), which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.” Read more

Beyond the Data

In his “Beyond the Data” columns, Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

Americans May Be Smarter About Vaccines Than You Think

In a new column that analyzes recent KFF polling, Founding President and CEO Dr. Drew Altman concludes that only a sliver of the public hold definitive anti-science, anti-vaccine views, and are greatly outnumbered by the people who believe established science, with even more Americans stuck in a “muddled middle.” He writes, “when you see reports of social media engagement spiking about a health myth, don’t overreact. It’s more likely than not that it’s a relatively small group of Americans who already believe it talking to themselves, and they are vastly outnumbered by those who believe the science.”

Filter

221 - 230 of 346 Results

  • Medicare-for-All vs. Single Payer: The Impact of Labels

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, "Medicare-for-All vs. Single Payer: The Impact of Labels", Drew Altman uses new polling on a Medicare-for-all or single payer health system to explain how what you call a health reform plan can substantially affect the public's response.

  • Behind the Challenges to Universal Health Coverage

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why political reality and the diverse makeup of the remaining uninsured population mean that the likeliest path to universal coverage is a multi-step approach.

  • What New Data Tell Us About Doctor Choice

    From Drew Altman

    Drew Altman explores the rhetoric versus reality on whether choice of doctors is eroding and why the issue resonates with Americans, in this column for The Wall Street Journal's Think Tank.

  • How Health-Care Bills Hinder Millions of Americans

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the problems many Americans with health insurance are having paying medical bills based on a new Kaiser-New York Times Survey, and discusses why the issue of the adequacy of insurance coverage is gaining traction.

  • How High Drug Prices Weigh on the Sickest Americans

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem.

  • Bernie Sanders, Hillary Clinton, and Medicare for All

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the differing positions of presidential candidates Hillary Clinton and Bernie Sanders on a single payer or Medicare-for-all health care system and whether Democratic voters consider it an important factor in the 2016 primaries.